ZENTALIS PHARMACEUTICALS INC. - COMMON STOCK
3.2200
24-December-24 13:45:00
15 minutes delayed
Stocks
+0.0400
+1.26%
Today's range
3.1350 - 3.2600
ISIN
N/A
Source
NASDAQ
-
Zentalis Pharmaceuticals Announces Key Management Appointments
12 Dec 2024 07:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 Dec 2024 16:35:10 By Nasdaq GlobeNewswire
-
13 Nov 2024 08:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Nov 2024 19:04:44 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold on Azenosertib Studies
16 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals to Present Preclinical Azenosertib Data at ESMO 2024
09 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 Sep 2024 16:40:50 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Progress
09 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Aug 2024 18:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Jul 2024 18:00:47 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program
18 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 Jun 2024 18:00:55 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
30 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
29 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit
14 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress
07 May 2024 07:00:01 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 May 2024 17:30:00 By Nasdaq GlobeNewswire
-
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Apr 2024 17:30:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >